QA: Corcept Therapeutics INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001088856_2013_Corcept_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001088856, Corcept Therapeutics INC

  xvar xval
0 AssetsCurrent 95,062,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 150,000
3 remainder_Assets 3,954,000
4 LiabilitiesCurrent 8,359,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 91,000
8 SellingGeneralAndAdministrativeExpense 25,414,000
9 ResearchAndDevelopmentExpense 14,074,000
10 remainder_Expenses 1,776,000
11 remainder_Revenues 3,307,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 99,166,000
1 Liabilities 8,359,000
2 Expenses 41,355,000
3 Revenues 3,307,000
4 StockholdersEquity 90,807,000
5 NetIncome -38,048,000
6 ComprehensiveNetIncome -38,048,000
7 BaseVar 76,093,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.97
9 EconomicCapitalRatio 3.67

Edgar->Model Mapping

Feature Distribution

Change over Time